Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-Plaque Benefit of Stannous Fluoride Gel
NCT03546491Phase 3Completed
- Sponsor
- Procter & Gamble
- Start
- May 2018
- Primary completion
- Jun 2018
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised trial of stannous fluoride in dental plaque (2 arms), sponsored by Procter & Gamble. Primary endpoint: Turesky Modified Quigley-Hein Index at Day 4. Started May 2018; status: completed.
02
Drugs
stannous fluoride
03
Conditions
dental plaque
Beyond the preview
Go deeper on NCT03546491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03546491.